Home / Letter From The Editor / April 20, 2019

April 20, 2019

Apr 20, 2019

I am not sure if you are like me, but often when I get a new medical journal or an online newsletter, I will take a look at the publication’s advisory board. From a personal perspective I like to see if I know any of them, and as a pharmacist I like to see if we are represented on the same advisory board. 

I also look at the articles to see if the advisory board members are just fancy names to lend credibility or if they actually participate in the journal. 

As you can guess we at Diabetes in Control have our own advisory board, and this week one of our most illustrious members, Dr. George Bakris, shares his opinions on the early stoppage of the 4,000 patient CREDENCE trial, and why that early stoppage is such a positive thing. 



We can make a difference!


Dave Joffe